Get the Stockscreener App
8.72
1.25%
-0.11
After Hours:
8.72
Kamada Ltd stock is traded at $8.72, with a volume of 92,044.
It is down -1.25% in the last 24 hours and up +1.04% over the past month.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
See More
Previous Close:
$8.83
Open:
$8.82
24h Volume:
92,044
Relative Volume:
0.86
Market Cap:
$503.23M
Revenue:
$181.68M
Net Income/Loss:
$20.37M
P/E Ratio:
24.95
EPS:
0.3495
Net Cash Flow:
$17.31M
1W Performance:
-1.47%
1M Performance:
+1.04%
6M Performance:
+6.34%
1Y Performance:
+30.34%
1-Day Range:
$8.71
$8.83
1-Week Range:
$8.65
$8.96
52-Week Range:
$6.50
$9.35
Kamada Ltd Stock (KMDA) Company Profile
Compare KMDA vs TAK, TEVA, HLN, ZTS, VTRS
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KMDA
Kamada Ltd
|
8.72 | 503.23M | 181.68M | 20.37M | 17.31M | 0.3495 |
TAK
Takeda Pharmaceutical Co Adr
|
18.86 | 60.23B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
39.19 | 45.71B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.26 | 40.72B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
71.05 | 29.36B | 9.51B | 2.64B | 2.14B | 6.0361 |
VTRS
Viatris Inc
|
17.83 | 20.48B | 14.57B | -296.50M | 1.64B | -0.259 |
Kamada Ltd Stock (KMDA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-21-25 | Initiated | The Benchmark Company | Buy |
| Jul-03-24 | Initiated | Stifel | Buy |
| Feb-02-18 | Initiated | Chardan Capital Markets | Buy |
Kamada Ltd Stock (KMDA) Latest News
Form 4 KAMADA LTD For: 26 September By Investing.com - Investing.com India
Big News: Lilach Payorski Adds $136K In Kamada Stock Options Io Portfolio - Benzinga
Amir London Makes Strategic Play: Invests $1.80M In Kamada Stock Options - Benzinga
Form 4 KAMADA LTD For: 25 September By Investing.com - Investing.com Canada
A special dividend changed the exercise prices on two stock-option awards for Kamada (KMDA)'s CEO. - Stock Titan
KAMADA LTD (NASDAQ: KMDA) Grants 86,500 Derivative Securities to Director Goldwasser Karnit - Kalkine Media
A dividend changed the exercise prices on options acquired by a Kamada (KMDA) director. - Stock Titan
Kamada (KMDA) HR VP receives two option awards that vest in four annual installments. - Stock Titan
Capitalizing On Growth Prospects, David Tsur Acquires A Substantial $59K In Kamada Stock Options - Benzinga
Capitalizing On Growth Prospects, Hanni Neheman Acquires A Substantial $115K In Kamada Stock Options - Benzinga
Nir Livneh Executes Major Move: Acquires $171K In Kamada Stock Options - Benzinga
Insider Activity Spotlight: Karnit Goldwasser Acquires $154K In Kamada Stock Options - Benzinga
Form 4 KAMADA LTD For: 24 September By Investing.com - Investing.com Canada
A special cash dividend led Kamada (KMDA) to adjust a VP’s stock option prices to $5.98 and $7.44. - Stock Titan
A cash dividend lowered the exercise prices of options awarded to Kamada (KMDA) counsel Nir Livneh. - Stock Titan
Kamada (KMDA) VP’s option prices were adjusted for a special dividend: $5.98 and $7.44 a share. - Stock Titan
Options for Kamada (KMDA) director Leon Recanati vest 25% a year and expire after 10 years. - Stock Titan
A special dividend changed the exercise prices on Kamada (KMDA) CFO's stock options. - Stock Titan
Dividend-linked option reset for Kamada (KMDA) VP - Stock Titan
KAMADA LTD (NASDAQ: KMDA) Director Tsur David Granted 37,500 Derivative Securities on August 27, 2026 - Kalkine Media
Kamada (KMDA) director reports 46,000 options at $6.10–$7.38 - Stock Titan
Kamada (NASDAQ: KMDA) grants director 46,000 options; exercise prices adjusted for dividend - Stock Titan
Stock options for Kamada (NASDAQ: KMDA) VP priced at $5.98 and $7.44 - Stock Titan
David Tsur Executes Major Move: Acquires $61K In Kamada Stock Options - Benzinga
Form 4 KAMADA LTD For: 23 September By Investing.com - Investing.com India
Special-dividend-adjusted options for Kamada (KMDA) VP - Stock Titan
Three option awards for a Kamada (KMDA) director carry prices from $5.99 to $7.41 per share. - Stock Titan
Kamada Ltd. stock holds gains after recent move in healthcare sector - AD HOC NEWS
Kamada Stock Price Forecast. Should You Buy KMDA? - StockInvest.us
StoneX reiterates Kamada stock buy rating on rabies treatment supply By Investing.com - Investing.com India
Kamada Ltd. (KMDA) Stock Analysis: A Healthcare Gem With 55.71% Potential Upside - DirectorsTalk Interviews
Kamada VP of Quality Yael Brenner Executes Five Stock Option Grants on September 14, 2026 - Kalkine Media
Kamada Ltd Director David Tsur Sells 22,827 Shares in September 2026 Transaction - Kalkine Media
Kamada (NASDAQ: KMDA) VP exercises options, uses 7,395 shares to cover costs - Stock Titan
Net option move leaves Kamada (KMDA) legal chief 3,459 shares - stocktitan.net
Kamada Maintains 'Sufficient' KedRAB Supply, Production Capacity Amid Increasing Rabies Exposures in US - marketscreener.com
Kamada Assures Adequate KedRAB Supply as U.S. Rabies Exposures Surge - TipRanks
Rising U.S. rabies exposures test supply; Kamada (NASDAQ: KMDA) says it is ready - Stock Titan
About 1.4 million people seek rabies care yearly. Kamada says supply is ready. - Stock Titan
CDC Highlights Significant Increase in U.S. Rabies Exposures and Anti-Rabies Immunoglobulin Utilization; Kamada Confirms Sufficient KedRAB® Supply to Meet Increased Demand - Yahoo Finance
KAMADA LTD SEC Filing (Sep 16, 2026) - Stock Titan
KAMADA (NASDAQ: KMDA) Director Tsur David Sells 177,173 Shares in Three Deals Between Sept 7-9, 2026 - Kalkine Media
Co-Founder & Independent Deputy Chairman of the Board David Tsur Sold A Bunch Of Shares In Kamada - simplywall.st
Kamada director David Tsur disposes of USD 1.47 million in ordinary shares - Bitget
Director David Tsur Sells 177,173 Shares of Kamada Ltd (KMDA) - gurufocus.com
Kamada Ltd Director David Tsur Executes Three Consecutive Sales of Ordinary Shares - kalkinemedia.com
Kamada (KMDA) director sells shares over three days - Stock Titan
Kamada CEO to Present Growth Strategy at H.C. Wainwright Global Investment Conference - The Globe and Mail
Kamada to Present at the H.C. Wainwright 28th Annual Global Investment Conference - The Manila Times
Kamada (KMDA) sets out a four‑pillar growth strategy - Stock Titan
Kamada's CEO is scheduled to speak in New York Sept. 15 - Stock Titan
Kamada Ltd Stock (KMDA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.18%
0.69%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):